NCCN Guidelines® icon
NCCN Patient Guides for Cancer icon
NCCN Reimbursement Resource icon

National Comprehensive Cancer Network®

3apps3.9(52)Medical

Publisher DNA

What defines National Comprehensive Cancer Network®?

AI intelligence is not yet available for National Comprehensive Cancer Network®. The portfolio data below is up to date.

Portfolio

What does National Comprehensive Cancer Network® ship?

Apps

3 apps analysed

Analysis in progress

Oncology professionals frequently recommend the resource to newly diagnosed patients for its clear educational value

  • Medical guidelines written in accessible language help patients share information with their caregivers and family
  • General user feedback post-update indicates the experience is merely acceptable rather than highly functional

Single-market publisher, every app ships only to United States.

Based on 1 of 3 apps with localized market data, more coverage rolling in as scans complete · last scanned .

Americas (1)

  • United States1 / 1

Core markets (1/1 apps)

United States

User Sentiment

How do users feel about their apps?

1

Positive apps

0

Neutral / mixed

0

Negative apps

75/100

Avg sentiment score

Frequently asked questions

How many apps does National Comprehensive Cancer Network® publish?
National Comprehensive Cancer Network® has 3 apps tracked by Marlvel, primarily in the Medical category.
What kind of apps does National Comprehensive Cancer Network® make?
National Comprehensive Cancer Network®'s portfolio is concentrated in Medical, with an average rating of 3.9/5 across rated apps.
What is National Comprehensive Cancer Network®'s top app?
By review volume across the portfolio, NCCN Patient Guides for Cancer is National Comprehensive Cancer Network®'s best-known app tracked by Marlvel.
In how many countries are National Comprehensive Cancer Network®'s apps available?
Marlvel has tracked National Comprehensive Cancer Network®'s apps across 1 country.

Disclosure: Independent intel to help mobile builders succeed.

AI-powered analysis with automated quality gates, built from publicly available sources. Marlvel.ai is not affiliated with, endorsed by, or sponsored by National Comprehensive Cancer Network®, its developer, the app publisher, Apple, or Google Play. All trademarks, logos, and screenshots referenced remain the property of their respective owners.

Cite this report

Marlvel.ai. “National Comprehensive Cancer Network® intelligence.” Updated N/A. https://marlvel.ai/publishers/national-comprehensive-cancer-network

See methodologyContact support

Data licensed under CC-BY-NC 4.0